Xencor Inc - 8-K Filing
Xencor reports Q3 2026 results and provides clinical updates for lead oncology candidate XmAb819 (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $XNCR
Read the full article at SEC EDGAR
Part of the story UNITY BANCORP INC /NJ/ - 8-K Filing (116 articles)